A heterochronic genetic change from an EGFR mutation to an ALK rearrangement in a patient with lung adenocarcinoma: a case report

An 87-year-old man with postoperative recurrent lung adenocarcinoma was treated with gefitinib. At the beginning of treatment, surgically resected archived tumor tissue revealed a deletion in exon 19 of the EGFR gene, but no ALK gene rearrangement. After gefitinib treatment for 9 months, the disease...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Thorac Dis
Glavni autori: Shiroyama, Takayuki, Tamiya, Motohiro, Hayama, Manabu, Nishihara, Takashi, Nishida, Takuji, Tanaka, Ayako, Morishita, Naoko, Suzuki, Hidekazu, Okamoto, Norio, Kawahara, Kunimitsu, Hirashima, Tomonori
Format: Artigo
Jezik:Inglês
Izdano: AME Publishing Company 2016
Teme:
Case Report
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4842787/
https://ncbi.nlm.nih.gov/pubmed/27162697
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2016.03.43
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items